Recombine is a clinical genetic testing company that facilitates informed medical decisions for patients and providers through innovative products and collaborative research. Our products are built on cutting-edge technologies, and our company is driven by experts in diverse fields who share a vision of a world where the power of personalized genomics is fully harnessed. Recombine’s affordable tests and in-depth genetic counseling services deliver valuable insights to thousands of patients worldwide through our robust network of respected physicians. We leverage the power of big data to achieve new perspectives on the science and delivery of genetics in the realm of fertility and beyond. We are strongly committed to being your partner in genomics as we pursue innovative genetic approaches to improving health outcomes.
Company Growth (employees)
New York, US
Size (employees)
41 (est)-2%
Recombine was founded in 2011 and is headquartered in New York, US

Key People at Recombine

Alexander Bisignano

Alexander Bisignano

Co-Founder & CEO
Neha Kumar

Neha Kumar

Director of Operations & Associate Genetic Counselor

Recombine Office Locations

Recombine has an office in New York
New York, US (HQ)
1100 1140 Broadway

Recombine Data and Metrics

Summary Metrics

Founding Date


Total Funding

$3.3 m

Latest funding size

$3.3 m

Time since last funding

over 3 years


Recombine's latest funding round in March 2014 was reported to be $3.3 m. In total, Recombine has raised $3.3 m

Traffic Overview of Recombine

Recombine Online and Social Media Presence

Recombine News and Updates

Phosphorus genomics startup raises $10 million to test fertility

 As the world of DNA sequencing becomes more efficient and less expensive, a number of companies are sprouting up within the space. The latest, Phosphorus, has just raised a $10 million Series A led by FirstMark. Phosphorus is actually a spin-out from a previous genomics company called Recombine, wh…

Recombine Company Life and Culture

You may also be interested in